Publication date: 10 June 2018 Source:Journal of Controlled Release, Volume 279 Author(s): Heather Nesbitt, Yingjie Sheng, Sukanta Kamila, Keiran Logan, Keith Thomas, Bridgeen Callan, Mark A. Taylor, Mark Love, Declan O'Rourke, Paul Kelly, Estelle Beguin, Eleanor Stride, Anthony P. McHale, John F. Callan Pancreatic cancer...

Publication date: 10 June 2018 Source:Journal of Controlled Release, Volume 279 Author(s): Hen Popilski, Esther Abtew, Steven Schwendeman, Abraham Domb, David Stepensky The effect of topical co-administration of promoter drugs with paclitaxel to increase anti-tumor effects of paclitaxel was investigated. Mice with orthotopic 4T1-Luc breast...

Publication date: 28 April 2018 Source:Journal of Controlled Release, Volume 276 Author(s): Elizabeth Q. Littauer, Lisa K. Mills, Nicole Brock, E. Stein Esser, Andrey Romanyuk, Joanna A. Pulit-Penaloza, Elena V. Vassilieva, Jacob T. Beaver, Olivia Antao, Florian Krammer, Richard W. Compans, Mark R. Prausnitz, Ioanna Skountzou...

Publication date: Available online 13 April 2018 Source:Journal of Controlled Release Author(s): Eunji Choi, Jungju Oh, Dahee Lee, Jaewon Lee, Xiaonan Tan, Minkyung Kim, Gyeungyun Kim, Chunxian Piao, Minhyung Lee The receptor for advanced glycation end-products (RAGE) is involved in tumor angiogenesis. Inhibition of RAGE might...

Publication date: 28 May 2018 Source:Journal of Controlled Release, Volume 278 Author(s): Yaqin Zhu, Yu Jiang, Fenghua Meng, Chao Deng, Ru Cheng, Jian Zhang, Jan Feijen, Zhiyuan Zhong Glioma is a highly challenging human malignancy as drugs typically exhibit a low blood-brain barrier (BBB) permeability as well as poor glioma selectivity...

Publication date: 28 April 2018 Source:Journal of Controlled Release, Volume 276 Author(s): Quanying Bao, Bryan Newman, Yan Wang, Stephanie Choi, Diane J. Burgess In vitro drug release testing and ex vivo transcorneal drug permeation can provide valuable information on the performance of the Q1/Q2 equivalent ointments prior to any animal...